MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David G. Benditt, MD
University of Minnesota
Study Chair - Theodore Chow, MD
The Lindner Center for Research and Education
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
47 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Mobile, Alabama, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Walnut Creek, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Hartford, Connecticut, United States
- Facility name not stated
Hollywood, Florida, United States
- Facility name not stated
Naples, Florida, United States
- Facility name not stated
Safety Harbor, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Joliet, Illinois, United States
- Facility name not stated
Springfield, Illinois, United States
- Facility name not stated
Beech Grove, Indiana, United States
- Facility name not stated
Kansas City, Kansas, United States
- Facility name not stated
New Orleans, Louisiana, United States
- Facility name not stated
Hyannis, Massachusetts, United States
- Facility name not stated
Grand Rapids, Michigan, United States
- Facility name not stated
Saginaw, Michigan, United States
- Facility name not stated
Saint Joseph, Michigan, United States
- Facility name not stated
Minneapolis, Minnesota, United States
- Facility name not stated
Omaha, Nebraska, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
East Islip, New York, United States
- Facility name not stated
Flushing, New York, United States
- Facility name not stated
West Islip, New York, United States
- Facility name not stated
Gastonia, North Carolina, United States
- Facility name not stated
Greensboro, North Carolina, United States
- Facility name not stated
High Point, North Carolina, United States
- Facility name not stated
Raleigh, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Columbus, Ohio, United States
- Facility name not stated
Toledo, Ohio, United States
- Facility name not stated
Doylestown, Pennsylvania, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Scranton, Pennsylvania, United States
- Facility name not stated
Spartanburg, South Carolina, United States
- Facility name not stated
Chattanooga, Tennessee, United States
- Facility name not stated
Germantown, Tennessee, United States
- Facility name not stated
Amarillo, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2003
- Primary completion
- 28 Feb 2007
- Completion
- 28 Feb 2007
- Last update posted
- 13 Feb 2008
- Registered enrollment
- 405
- Registry id
- NCT00305214
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.